FDA Inspection 807491 — Janssen Pharmaceuticals, Inc
The FDA completed an inspection of Janssen Pharmaceuticals, Inc on Nov 16, 2012 in Titusville, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 16, 2012
- Fiscal Year
- 2013
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Titusville, NJ (United States)
Additional Details
Sponsor, Contract Research Organization